SINGAPORE – A new programme has been launched in Singapore to formally study the applications of ribonucleic acid (RNA) in vaccine development, as well as in disease therapy and prevention ...

In 2022 the organizers of CASP turned their attention towards a different, yet still challenging, class of biomolecules: RNA. As with proteins, determining RNA structure typically requires costly ...